文献速递血栓与止血

PlateChek:一种表面功能化介电微传感器,用于特异性检测全血中血小板相关止血功能障碍

PlateChek: a surface-functionalized dielectric microsensor for specific detection of platelet-related hemostatic impairment in whole blood.
PubMed 文献 · J Thromb Haemost · 2025-12-23

研究开发了PlateChek——一种基于全血、以凝血酶受体激活肽-6(TRAP-6)包被金电极表面的介电凝血微传感器,并在体外模拟及临床样本中测试其检测血小板数量与功能缺陷所致止血障碍的能力。结果显示PlateChek对血小板计数<50 k/μL时凝血动力学延迟、<100 k/μL时血凝块硬度降低敏感,并能检测沃拉帕沙抑制所致凝血时间延长、替罗非班抑制所致血凝块硬度降低,以及临床样本中血小板计数<70 k/μL和血小板聚集功能障碍。结论认为PlateChek是一种具有转化潜力的新型全血凝血仪,可将血小板计数和功能缺陷与止血障碍直接关联。

要点

  • PlateChek以TRAP-6包被金电极实现血小板特异性凝血检测。
  • 对血小板计数<50 k/μL凝血动力学延迟、<100 k/μL血凝块硬度降低敏感。
  • 可检测沃拉帕沙和替罗非班抑制及临床血小板聚集功能障碍。

核心结论

  • PlateChek是一种具有转化潜力的新型全血凝血仪,可将血小板计数和功能缺陷与止血障碍直接关联。

研究设计与样本

  • 研究开发了PlateChek全血介电凝血微传感器,使用金电极表面包被血小板特异性激动剂TRAP-6。
  • 采用体外操控的健康血液模拟血小板计数或功能缺陷,并用血小板减少症或血小板聚集功能障碍患者的血样进行验证。

主要发现

  • 在PlateChek中,与健康对照相比,血小板计数<50 k/μL的样本凝血动力学延迟。
  • 血小板计数<100 k/μL时血凝块硬度降低。
  • PlateChek对沃拉帕沙抑制所致的凝血时间延长敏感。
  • PlateChek对替罗非班抑制所致的血凝块硬度降低敏感。
  • PlateChek对临床血样中血小板计数<70 k/μL及血小板聚集功能障碍敏感。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Platelet count or function defects can result in hemostatic impairment, leading to life-threatening bleeding complications. While platelet transfusions are used to treat such complications, current clinical practice utilizes only platelet count thresholds to guide transfusion. This is because a single precision diagnostic system that can directly correlate both platelet count and function defects to hemostatic deficits is unavailable. OBJECTIVES: We developed PlateChek, a whole blood-based dielectric coagulometry microsensor that uses a gold electrode surface coated with a platelet-specific agonist, and tested the hypothesis that PlateChek can detect hemostatic impairment due to both platelet count and function defects. METHODS: PlateChek incorporates a gold electrode coated with thrombin receptor-activating peptide (TRAP)-6 to render clotting in a platelet-specific manner. Healthy blood was manipulated in vitro to recapitulate platelet count or function defects and tested in PlateChek to assess platelet-specific readout signatures. Finally, blood samples from patients with thrombocytopenia or platelet aggregation dysfunctions were used to validate PlateChek's ability to detect clinically relevant hemostatic impairment. RESULTS: In PlateChek, clotting kinetics were delayed in samples with platelet counts of < 50 k/μL compared to healthy controls and clot firmness was reduced with platelet counts of < 100 k/μL. PlateChek was sensitive to prolonged clotting time induced by vorapaxar inhibition and reduced clot firmness induced by tirofiban inhibition. PlateChek was sensitive to platelet counts of < 70 k/μL and platelet aggregation dysfunctions in clinical blood samples. CONCLUSION: PlateChek is a novel whole blood-based coagulometer with translational potential that directly correlates both platelet count and function defects to hemostatic impairment.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Disharoon D, Pourang S, Delianides CA, et al. PlateChek: a surface-functionalized dielectric microsensor for specific detection of platelet-related hemostatic impairment in whole blood. J Thromb Haemost. 2025. PMID: 41448540. doi:10.1016/j.jtha.2025.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。